Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Sacks

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
NPJ Digital Medicine|November 30, 2024
Phenotyping people with a history of injecting drug use within electronic medical records using an interactive machine learning approachCarol El-Hayek, Thi Nguyen, Margaret E Hellard, et al.
Plos One|September 2, 2016
Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual MenDaniel Bradshaw, Jayna Raghwani, Brendan Jacka, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2021
A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, AustraliaBrendan L Harney, Bradley Whitton, Emma Paige, et al.
Sexually Transmitted Infections|June 20, 2024
Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance dataBrendan L Harney, Rachel Sacks-Davis, Michael Traeger, et al.
The Medical Journal of Australia|November 18, 2020
Modelling the impact of relaxing COVID-19 control measures during a period of low viral transmissionNick Scott, Anna Palmer, Dominic Delport, et al.
Frontiers in Immunology|February 29, 2024
Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapyAnna C Hearps, Nikil Vootukuru, Salimeh Ebrahimnezhaddarzi, et al.
Journal of the International AIDS Society|April 11, 2018
Linkage and retention in HCV care for HIV-infected populations: early data from the DAA eraRachel Sacks-Davis, Joseph S Doyle, Andri Rauch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2025
Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis CJim Young, Shouao Wang, Rachel Sacks-Davis, et al.
Journal of Viral Hepatitis|June 20, 2022
Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugsMichael W Traeger, Daniela K van Santen, Rachel Sacks-Davis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2024
Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020Brendan L Harney, Rachel Sacks-Davis, Daniela K van Santen, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
NPJ Digital Medicine|November 30, 2024
Phenotyping people with a history of injecting drug use within electronic medical records using an interactive machine learning approachCarol El-Hayek, Thi Nguyen, Margaret E Hellard, et al.
Plos One|September 2, 2016
Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual MenDaniel Bradshaw, Jayna Raghwani, Brendan Jacka, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2021
A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, AustraliaBrendan L Harney, Bradley Whitton, Emma Paige, et al.
Sexually Transmitted Infections|June 20, 2024
Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance dataBrendan L Harney, Rachel Sacks-Davis, Michael Traeger, et al.
The Medical Journal of Australia|November 18, 2020
Modelling the impact of relaxing COVID-19 control measures during a period of low viral transmissionNick Scott, Anna Palmer, Dominic Delport, et al.
Frontiers in Immunology|February 29, 2024
Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapyAnna C Hearps, Nikil Vootukuru, Salimeh Ebrahimnezhaddarzi, et al.
Journal of the International AIDS Society|April 11, 2018
Linkage and retention in HCV care for HIV-infected populations: early data from the DAA eraRachel Sacks-Davis, Joseph S Doyle, Andri Rauch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2025
Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis CJim Young, Shouao Wang, Rachel Sacks-Davis, et al.
Journal of Viral Hepatitis|June 20, 2022
Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugsMichael W Traeger, Daniela K van Santen, Rachel Sacks-Davis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2024
Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020Brendan L Harney, Rachel Sacks-Davis, Daniela K van Santen, et al.
Pageof 12